Immunotherapy in Combination with Chemotherapy for Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer that lacks estrogen and progesterone receptors and does not overexpress the human epidermal growth factor receptor 2 (HER2). Previous treatment options for TNBC were limited to chemotherapy alone, resulting in a poor pati...
Shranjeno v:
| Drugi avtorji: | , , |
|---|---|
| Format: | Artículo |
| Jezik: | en_US |
| Izdano: |
2023
|
| Teme: | |
| Online dostop: | https://doi.org/10.2174/1389557523666230517152538 https://pubmed.ncbi.nlm.nih.gov/37198990/ |
| Oznake: |
Označite
Brez oznak, prvi označite!
|
Komentirajte kot prvi!